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ABSTRACT  
Background: Psychosocial Interventions (PIs) have shown positive effects on clinical and 
functional outcomes of schizophrenia (SZ) in randomized controlled trials. However their 
effectiveness and accessibility remain unclear to date in “real world” schizophrenia.  
Objectives: (i) To assess the proportion of service users with SZ who received PIs between 
2013 and 2015 in France after an Expert Center intervention in a national multicentric non-
selected community-dwelling sample; (ii) to assess PIs effectiveness at one-year follow-up. 
Methods: 183 SZ outpatients were recruited from FondaMental Advanced Centers of 
Expertise for Schizophrenia cohort and followed-up at one year. Baseline and one-year 
evaluations included sociodemographic data, current treatments, illness characteristics, 
addictive behaviors and standardized scales for clinical severity, adherence to treatment, 
quality of life, a large cognitive battery, and daily functioning assessment.  
Results: 64 (35%) of the 183 participants received at least one PI during the one-year follow-
up. Having had at least one PI has been associated in multivariate analyses with significantly 
higher improvement in positive and negative symptoms (respectively p=0.031; p=0.011), 
mental flexibility (TMT B, p=0.029; C-VF, p=0.02) and global functioning (p=0.042). 
Cognitive behaviour therapy (CBT) and social skills training (SST) were associated with 
higher cognitive improvements (in speed of processing and mental flexibility), while 
cognitive remediation (CRT) was associated with clinical improvement, beyond cognitive 
symptoms. These results have not been demonstrated before and suggest that the effect of 
each PI is larger than its initial target (i.e. positive/negative symptoms for CBT, cognition for 
CRT). 
Conclusion: The present study has confirmed the PIs’ effectiveness in a large sample of 
community-dwelling SZ outpatients at one year follow-up. Efforts to improve access to PI 
should therefore be reinforced in public health policies.  
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 Introduction 
The concept of recovery has begun to transform practices and mental health systems 
throughout the world, switching from symptom-reduction to improved functioning and 
quality of life outcomes
 
(Slade et al., 2014). Recovery may be defined either from a clinical 
perspective (i.e. clinical and functional remission) or from a consumer-oriented one, as a self-
broadening process aiming at living a meaningful life beyond mental illness (Roe et al., 2011). 
In a recent meta-analysis, only 13.5% of the persons with schizophrenia (SZ) met the criteria 
for clinical recovery (   s el inen et al., 2013).  
A growing bundle of evidence suggests that this proportion could be deeply improved by 
Psychosocial Interventions (PIs) including psychoeducation (PSE), cognitive remediation 
therapy (CRT), cognitive behaviour therapy (CBT) and social skills training (SST). PSE has 
shown effectiveness in reducing psychotic relapse rates and medication non-adherence (Xia et 
al., 2011). CRT has shown effectiveness in improving cognitive and psychosocial functioning 
(MacGurk et al., 2007; Wykes et al., 2011). CBT has shown effectiveness in positive and 
negative symptoms and psychosocial functioning (Wykes et al., 2008). SST has shown 
improvement on social and daily living skills, community functioning, negative symptoms 
and relapses (Kurtz et Mueser, 2008). All PIs appear to remain effective at one-year follow-up 
(Xia et al., 2011; MacGurk et al., 2007; Wykes et al., 2011; Wykes et al., 2008), except for 
SST where it is less clear due to a lack of follow-up data (Kurtz et al., 2008). In summary, 
each PI has shown some effectiveness in specific domains, but no longitudinal study has 
evaluated their global effectiveness in real-world conditions (Menear et Briand, 2014). 
Moreover, PIs remain poorly available to service users with SZ in Western Countries: in 2010 
only 15% of the 6007 participants with SZ in the French cohort ESPASS (Leguay et al., 2010) 
and 36.5% of the 1825 persons with SZ in the 2
nd
 Australian National Survey (Morgan et al., 
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2012) were engaged in any form of psychosocial rehabilitation (including PIs, family 
interventions and sheltered or competitive employment). 
 The objectives of the present study were: (i) to assess the proportion of service users who 
received PIs between 2010 and 2015 in France after an Expert Center Intervention in a 
national multicentric non-selected community-dwelling SZ sample; (ii) to assess PIs 
effectiveness at one-year follow-up. 
 
2. Material and methods 
2.1. Study population 
The FACE-SZ cohort is based on an ongoing French national network of schizophrenia 
Expert Centers that has been extensively described in a previous article (Sch rhoff et al., 
2015). Service users are referred to Expert Centers by their general practitioner or psychiatrist, 
who remains in charge or routine care and treatment. Patients are yearly followed-up at the 
Expert Center and at the end of each evaluation a detailed evaluation report is sent to the 
patient and the referrer along with a personalized care program multifaceted and including the 
rationale for PI recommendation. The appraisal protocol was approved by the relevant Ethical 
Review Board (CPP-Ile de France IX) on January 18, 2010. All participants gave their written 
informed consent.  
 
2.2. Data collected 
General information on education, marital status, economic status, illness onset and trajectory 
and comorbidities, was recorded. Illness severity was assessed using the Positive and 
Negative Syndrome (PANSS) (Kay et al., 1987) and the Clinical Global Impression (CGI) 
scales (Haro et al., 2003). Current depressive symptoms were evaluated using the Calgary 
Depression Rating Scale for Schizophrenia (CDSS) (Addington et al., 1993). Insight was 
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measured both with a self-reported measure (Birchwood Insight Scale; BIS) (Birchwood et al., 
1994) and with the clinician-rated Scale to assess Unawareness of illness in Mental Disorders 
(SUMD) (Amador, 1990). Adherence into treatment was self-reported with the Medication 
Adherence Rating Scale (MARS) (Thompson et al., 2000) therapeutic observance being 
evaluated by clinicians with the Brief Adherence Rating Scale (BARS) (Byerly et al., 2008). 
Quality of Life was evaluated with the self-reported Subjective Quality of Life scale (S-QoL) 
(Auquier et al., 2003). General Functioning was measured with the Global Assessment of 
Functioning scale (GAF) (Startup et al., 2002). Neuropsychological baseline and one year 
cognitive assessments included verbal fluency (L-VF; C-VF) (Godefroy et le GREFEX,
 
2008) 
for spontaneous mental flexibility, Trail Making Test A and B (TMT-A or B)) (Godefroy et le 
GREFEX,
 
2008)
 
respectively for speed of processing and reactive mental flexibility, 
Continuous Performance Test-Identical Pair version (CPT-IP)
 
(Cornblatt et al., 1988) for 
sustained attention implying working memory mechanisms and premorbid IQ with the 
French-National Adult Reading Test (f-NART) (Mackinnon et Mulligan, 2005). To avoid 
test-retest effects, Intelligence Quotient (IQ) was assessed only at baseline with Wechsler 
Adult Intelligence Scale-4
th
 edition (WAIS-IV) (Wechsler, 2008).  
 
Psychosocial intervention definition 
The “PI+” group was defined as service users following at least one PI during the one-
year follow-up among manualized and standardized group psychoeducation (PSE), group 
cognitive behaviour therapy (CBT), group social skills training (SST) and individual and 
group cognitive remediation therapy (CRT) (Khazaal et al., 2015; Briki et al., 2014;  Franck 
et al., 2013; D’Amato et al., 2011; Roder et al., 2011; Twamley et al., 2012; Bazin et al., 
2010). Beginning and ending dates of interventions were systematically recorded and only 
participants who completed at least 75% of the sessions were considered as PI+.  
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2.3. Statistical Analysis 
Clinical and functional outcomes were compared at baseline (“V0” visit) and after one year of 
follow-up (“V1”). For each outcome variable, improvement was defined as the difference 
between the values at V0 and V1, oriented so that a positive difference should correspond to 
an improvement of the patient’s condition. Each difference was adjusted by a linear 
regression over its confounding value at V0. Seventeen variables of interest were chosen: 
positive, negative, general psychopathology subscale scores and total score for PANSS, 
scores of the CDSS, CGI, GAF, S-QoL, BIS, and MARS, awareness and attribution scores of 
SUMD, number of words in the two verbal fluency tests, time at the TMT A and B, and d 
prime score in the fourth condition of the CPT-IP.  
In the univariate analysis, the seventeen adjusted differences were compared to having had or 
not CBT, CRT, PSE, SST; having had or not at least one PI; the one-sided Student T-test was 
used. The one-sided correlation test between the seventeen adjusted improvement variables 
and the number of PIs was also computed. Results are shown on Table 2. 
In the multivariate analysis, the same seventeen adjusted improvements were considered as 
responses. Having had or not at least one PI was retained as a predictor. The values at V0 of 
the seventeen variables of interest were considered as covariates. Fifteen factors were added: 
(age at V0, age at first episode, level of education, memory score, IQ, gender, housing 
(independent or not), professional status (unemployed or not), diagnosis (schizophrenia vs. 
schizo-affective disorder), psychotic episodes, suicide attempts and full time hospitalizations 
during past year, alcohol and cannabis consumptions, treatment type (second generation vs. 
first generation antipsychotics)). Thus improvement for each variable of interest was tested 
against a set of thirty-three potentially explanatory factors, including the predictor. Univariate 
significance p-values were computed, and covariates significant at the 10% level were 
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included in a regression model. Exhaustive variable selection determined the best model in 
the sense of adjusted R-squared. 
Data was analysed using the R software, version 3.2.3 (Wechsler, 2008). The psych package 
version 1.5.8, was used (R Core Team, 2015). Effect Size (Cohen's d) was calculated using 
package effsize (Revelle, 2015). Size effects inferior to 0.20 were considered as negligible, 
from 0.20 to 0.40 as small, from 0.40 to 0.60 as moderate and superior to 0.60 as strong 
(Revelle, 2015). For variable selection, the leaps package version 2.9 was used (Lumley, 
2009). The level of confidence intervals was set at 0.95, and the significance level of tests was 
set at 0.05. The initial data set had 9.23% missing data on average, over 54 variables of 
interest. The multivariate imputation method described in (Van Buuren, 2012) was applied, 
using the package mice (Van Buuren et Groothuis-Oudshoorn, 2012). Statistical treatments 
were first conducted using the standard pairwise deletion method, then repeated over 100 
imputed datasets. The tables report p-values from the pairwise deletion method; only 
conclusions remaining consistent through most imputed datasets were considered as 
significant. 
 
3. Results 
 
Overall, 183 stabilized SZ outpatients were included in the 10 centers of the FACE-SZ 
national cohort and followed-up for one year. The sample included mostly men (144, 78.7%), 
with a mean age of 33.9 (SD=10.26) years, mean illness duration of 11.1 (SD=9.19) years and 
a mean baseline PANSS total score of 69.9 (SD=17.38). Baseline sample characteristics are 
shown on Table 1. At inclusion, 7 (3.8%) patients had received at least one PI (CRT N=4, 
CBT N=2, SST N=1). Removing these patients did not change the results (data not shown).  
 64 (35%) had received at least one PI during the follow-up period: CRT (N=36, 19.7%), CBT 
(N=29, 15.8%), PSE (N=31, 16.9%) and SST (N=18, 9.8%). Overall, those with higher 
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baseline insight scores (p=0.007), better cognitive function and higher depressive symptoms 
(p=0.017) accessed more to at least one PI during the one-year follow-up. No clinical variable 
at baseline was associated with a specific PI except for higher depression level that was 
associated with CBT (p=0.017) (table 1). 
In the univariate analyses, having had at least one PI during the one-year follow-up has been 
significantly associated with improvement in negative symptoms (PANSS negative; d=0.44; 
p=0.003), insight (BIS; d=0.42; p=0.004), sustained attention/working memory (CPT-IP; 
d=0.48; p=0.023) and spontaneous and reactive mental flexibility (C-VF; d=0.57; p<0.001; 
TMT B; d=0.58; p=0.001) (Table 2). It was also correlated to mild improvements in positive 
symptoms (PANSS positive score; d=0.31; p=0.021), adhesion to treatment (MARS; d=0.35; 
p=0.024) speed of processing (TMT A; d=0.30; p=0.044) and global functioning (GAF score; 
d=0.37; p=0.012).  
PSE was associated with a moderate improvement of adherence into treatment (MARS score; 
d=0.53, p=0.006) and improvement in psychotic symptomatology (PANSS total score, d=0.47, 
p=0.008). 
CBT has been associated with moderate improvement in global functioning (GAF score, 
d=0.59, p=0.001), spontaneous mental flexibility (C-VF, d=0.58, p=0.003) clinical global 
severity (CGI, d=0.46, p=0.010) and to mild improvement in positive symptoms (d=0.34, 
p=0.026) and speed of processing (TMT A, d=0.34, p=0.012). CBT was however also 
associated with decreased quality of life (S-QoL, p=0.973).  
CRT has been associated with high improvement in reactive mental flexibility (TMT-B, 
d=0.77, p<0.001) and with moderate improvement of other cognitive processes (sustained 
attention / working memory CPT-IP; d=0.45; p=0.019; spontaneous mental flexibility C-VF; 
d=0.49 p=0.006) and both positive (d=0.42, p=0.007) and negative (d=0.47, p=0.005) 
symptoms. CRT was also found to have a mild effect on clinical global severity (CGI score 
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d=0.36 p=0.022) and on the level of insight into illness (SUMD awareness score d=0.38 
p=0.023; SUMD attribution score d=0.42 p=0.011).  
SST has been associated with moderate improvements in clinical severity (CGI score, d=0.44 
p=.015), spontaneous and reactive mental flexibility (C-VF; d=0.55 p=0.015; TMT B d=0.47 
p=0.006) and global functioning (GAF; d=0.46 p=0.005). Mild improvements have also been 
found on negative symptoms (d=0.25 p=0.044) and speed of processing (TMT A; d=0.38 
p=0.024). SST was however also associated with decreased quality of life (S-QoL, p=0.856). 
In the multivariate analysis, having had or not at least one PI was retained as the main 
explanatory factor for the improvement of positive (p=0.031) and negative (p=0.011) 
symptoms PANSS scores, clinical global severity CGI score (p=0.003), spontaneous and 
reactive mental flexibility (C-VF; p=0.002; TMT B, p=0.029) and global functioning GAF 
score (p=0.042).  
 
4. Discussion 
Altogether, the findings of the present study may be summarized as follows:  
(i) compared to the very low rates of service users with SZ benefiting from PIs outside of the 
Expert Centers network (12% of the 6007 participants in the 2010 ESPASS study (Leguay et 
al., 2010); 3.8% during the 12 months before evaluation in the present study), PIs were more 
frequently offered and delivered in the FACE network between 2010 and 2015 (35%).  
(ii) In a large sample of non-selected community-dwelling SZ service users followed-up 
during one year, those who received one of the 4 PIs improved significantly more on clinical 
symptomatology, mental flexibility and functioning at one year compared to those who did 
not. Moreover, CBT and SST have been associated with higher cognitive improvements (in 
speed of processing and mental flexibility), while CRT was associated with clinical 
improvement, beyond cognitive symptoms. These results have not been demonstrated before 
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and suggest that the effect of each PI is larger than its initial target (i.e. positive/negative 
symptoms for CBT, cognition for CRT).  
 As mentioned in the rationale, the access to PIs was extremely low in France before the 
development of the FACE-SZ network in 2009. Only 15% of the 6007 participants with SZ 
included in the ESPASS cohort were engaged in any form of psychosocial rehabilitation 
(including the 4 PIs, family interventions and sheltered or competitive employment) during 
the 6-months follow-up period; only 2% received CBT; 1% CRT; 2% SST and 7% PSE 
(Leguay et al., 2010). Similarly, only 3.8% of the participants included in the FACE cohort 
had received from at least one PI on the year before evaluation. Several barriers to the 
implementation of evidence-based interventions in routine clinical practice have been 
identified in the literature- including lack of available resource (Ince et al., 2016) lack of 
specific training (Ince et al., 2016; Kimhy et al., 2013), lack of dedicated time to perform 
interventions (Kimhy et al., 2013), excessive caseloads for a limited workforce capacity (Ince 
et al., 2016), staff members lack of knowledge about PIs and their efficacy (Ince et al., 2016; 
Kimhy et al., 2013), negative management and team attitude towards PIs (Kimhy et al., 2013), 
lack of service users sharing the same diagnosis for structured psychoeducation (Getachew et 
al., 2009) and difficulties to identify those who would need an intervention for CBT (Ince et 
al., 2016). One of the aims of the FACE-SZ expert center network is to widespread 
psychosocial interventions by increasing access to a comprehensive evaluation, to trained 
psychologists and to a personalized recovery-orientated plan of care. The present results 
suggest that expert center network is effective in increasing the rate of PIs delivery.  
 
More specifically, 15.8% of the 183 participants included in the present sample received 
CBT during the follow-up period. This is higher than the proportion found in UK in 2014 
(5.3% of 187 participants) (Haddock et al., 2014) but it remains less developed compared to 
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Australia (22.3% of 1825 participants) (Morgan et al., 2012). The development of a large 
Australian PI network since the 2000s beyond the national public health system in this 
country may explain this difference (Morgan et al., 2012). Access to PSE (16.9% in the 
present sample) was higher compared to the 2010 ESPASS study (7%) (Leguay et al., 2010)
 
but PSE is still less available than in German-speaking countries (21% of 338 participants in 
2003) (Rummel-Kluge et al., 2006). In these countries, PSE has been included in the national 
mental health policy. The proportion of service users who have received CRT and SST in the 
present study was much higher compared to the ESPASS 2010 study (Leguay et al., 2010) 
(respectively 19.1% vs. 1% for CRT and 9.8% vs 2% for SST). To the best of our knowledge, 
no comparative data has been published for other countries. 
 CBT is the most documented intervention regarding its effectiveness, access rates and 
implementation in national policies (Menear et Briand 2014; Ince et al., 2016; Kimhy et al., 
2013; Lewis et al., 1981). CBT has been associated in the present sample with improvements 
in positive symptoms but not negative symptoms, consistently with the findings of a previous 
study (d=0.37 (Wykes et al., 2008) vs. d=0.34 in the present study). Moreover, CBT has been 
independently associated with improvements in speed of processing and mental flexibility in 
the present results, which has not been demonstrated before. Improvements in speed of 
processing has been previously associated in recent studies with functional change during 
psychosocial rehabilitation (Rispaud et al., 2016) and to participation in community activities 
(Lepage et al., 2014). Improved mental flexibility has been associated with better functional 
outcomes (Lepage et al., 2014).  Future studies should determine whether improvement in 
cognitive functions mediates the relationship between CBT and the improvement in global 
functioning. The effect size of the improvement of global functioning associated with CBT 
was larger in the present study compared with previous studies  (d=0.59 in the present study 
vs. 0.38) (Wykes et al., 2008). The factors associated with effectiveness of CBT on global 
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functioning in service users with SZ should be explored in future studies. SST has shown 
moderate effects on global functioning in the present study, which is consistent with the 
results of a previous study (Kurtz et Mueser, 2008), (d=0.52 vs. d=0.46 in the present sample), 
however the effect size on negative symptoms was smaller in the present study (d=0.25 vs. 
d=0.40) (Kurtz et Mueser, 2008). SST was also associated with mild improvements in speed 
of processing and moderate improvements in mental flexibility in the present study. Speed of 
processing has been recently described as a mediator of social competence, interpersonal 
relationships and community functioning (Rispaud et al., 2016; Lepage et al., 2014). Mental 
flexibility has also been associated with social functioning and problem solving (Lepage et al., 
2014). Further studies should determine if the effect of SST on global functioning is mediated 
by the improvement in negative symptoms, social cognition (Varga et al, 2018), speed of 
processing and/or mental flexibility. Despite improved cognitive and symptoms outcomes 
CBT and SST appeared to worsen subjective quality of life. This might be linked to improved 
insight into illness and to increased awareness of their difficulties (Margariti, 2014).  
The present results suggest that PSE is associated with the improvement in adherence into 
treatment and clinical severity at one year, consistently with a previous study (Xia et al., 
2011).  
Consistently with some studies (MacGurk et al., 2007; Wykes et al., 2011), CRT has 
shown a moderate positive effect on cognitive functioning in the present study (d=0.42-0.77 
vs. d=0.36 (MacGurk et al., 2007); d=0.42 (Wykes et al., 2011)). CRT has been also 
associated in the present sample with moderate improvements in negative symptoms (d=0.47). 
This is consistent with the literature, although reported effects-sizes were smaller in a recent 
meta-analysis (Hedge’s g=0.30) (Cella et al., 2017). Future studies should determine whether 
improving executive functions might mediate the association between CRT and negative 
symptoms reduction, as suggested in a previous study (Farreny et al., 2013). This effect may 
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be mediated by specific CRT modules or by non-specific ones (e.g. contact with a therapist or 
attendance to sessions) (Vinogradov et al., 2013). In contrast with other studies (MacGurk et 
al., 2007; Wykes et al., 2011), CRT has however not been associated with improvement in 
global functioning in the present sample (p>0.05). Future studies should determine the 
parameters associated with the CRT effectiveness.  
Limits: Although the network of FondaMental Experts Center for Schizophrenia covers the 
whole French territory, it cannot be definitely asserted that the FACE-SZ database contains a 
representative sample of the French population of schizophrenic patients. However, some 
sample characteristics (including sex ratio, age at illness onset, comorbidities) suggest that the 
present sample may be compared to general stabilized community-dwelling SZ population. 
Institutionalized or very disabled patients are not able to receive a 2-day long comprehensive 
evaluation and were therefore not represented in the present sample, which limits the 
extrapolation of the present results to this population, as well as to patients younger than 16 
years.  
Strengths. Compared to the previous studies mentioned in the rationale, the present study 
exhibits clear strengths: a large non-selected sample of community-dwelling SZ outpatients, 
the use of a large bundle of standardized evaluation scales, and the inclusion of a large 
number of potential confounding factors in the multivariate analysis.  
 
Conclusion  
Psychosocial interventions have been associated with a large bundle of improvements in the 
present sample of SZ community-dwelling service users. Each therapy has shown 
effectiveness on its primary target (e.g. cognition for CRT, psychotic symptomatology for 
CBT) but also effectiveness on other dimensions (e.g. cognition for CBT, negative symptoms 
for CRT). The largest global effects of PIs were found for negative symptoms, sustained 
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attention / working memory and mental flexibility. Future health policies should determine 
which PI should be systematically proposed to each patient in a personalized/precision 
medicine approach to optimize accessibility, patient’s adherence and effectiveness.  
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